The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: An in vitro experiment

National Medical Journal of China

Volumn 88, Issue 4, 2008, Pages 271-275

  Zhang, Yu Xi ^a   Kong, Chui Ze ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Mitogen activated protein kinase; Prostate carcinoma; Raloxifene

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; RALOXIFENE; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NICK END LABELING; PROSTATE CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BONE DENSITY CONSERVATION AGENTS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENZYME INHIBITORS; FLAVONOIDS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMIDAZOLES; IN SITU NICK-END LABELING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRIDINES; RALOXIFENE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 41349087752     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Chinese source.
2. Olson KB, Pienta KJ. The treatment of hormone refractory prostate cancer. AUA Update Series,1999,18:26-31.
3. Lonard DM, Smith CL. Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions. Steroid, 2002, 67:15-24.
4. Kim IY, Kim BC, H Seong do, et al. Raloxifene, a mixed estrogen agonist/ antagonist, induces apoptosis in androgen independent human prostate cancer cell lines. Cancer Res,2002, 62:5365-5369.
5. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev,2001,81:807-869.
6. Mabuchi S, Ohmichi M, Kimura A, et al. Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin. Endocrinology,2004,145:1302-1313.
7. Lau KM, LaSpina M, Long J, et al. Expression of estrogen receptor(ER) α and ER-β in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res,2000,60:3175-3182.
8. Resnitzky D, Reed SI. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol Cell Biol,1995,15: 3463-3469.
9. Lavoie JN, L'Allemain G, Brunet A, et al. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/ HOGMAPK pathway. J Biol Chem,1996,271:20608-20616.
10. Xiong Y, Hannon C, Zhang H, et al. p21 is a universal inhibitor of cyclin kinases. Nature,1993,366:701-704.
11. Hayakawa J, Ohmichi M, Kurachi H, et al. Inhibition of extracellular signal regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J Biol Chem,1999; 274:31648-31654.
12. Kim GS, Hong JS, Kim SW, et al. Leptin induces apoptosis via ERK/cPLA2/ cytochrome c pathway in human bone marrow stromal cells. J Biol Chem,2003,278:21920-21929.
13. Zhang CC, Shapiro DJ. Activation of the p38 mitogen-activated protein kinase pathway by estrogen or 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis. J Biol Chem, 2000,275:479-486.